HomeBest options strategy › MRNA

Best Options Strategy for MRNA

By Dennis Bosmans · Updated 2026 · 2 min read · Risk disclaimer

Looking for the best options strategy for Moderna (MRNA)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live MRNA option chain right now, and a simple map from your view on MRNA to the strategy that fits it. Model any of them in the calculator before you trade.

About MRNA

Moderna (MRNA) is a major company in mRNA vaccines and therapeutics. Options traders on MRNA tend to watch vaccine demand, trial data and earnings, since these can drive large moves in the share price.

MRNA for options traders

Moderna is one of the most volatility-rich names in the biotech universe. Its implied volatility (IV) is structurally elevated because the company's revenue and pipeline outlook can swing dramatically on clinical trial readouts, regulatory decisions, partnership announcements, and shifts in public health policy. Earnings reports carry an added dimension: guidance revisions can reprice the stock sharply in either direction, and the options market prices that uncertainty into premiums well before the event.

Options liquidity is reasonably good for a mid-cap biotech, with active volume across near-term strikes and sufficient open interest to support multi-leg strategies. Long straddles and strangles are popular around binary catalysts — traders pay for the move without committing to direction. Between catalysts, when IV compresses, premium sellers turn to short straddles, iron condors, or covered calls to harvest inflated time value. Given the potential for gap-style moves, position sizing and defined-risk structures are especially important here.

Today's top-scoring strategy for MRNA

Our engine ranks defined-risk strategies on the live MRNA chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.

Long Call Butterfly neutral
Price: $100.00Implied volatility: 55%Expiration: 2026-07-17 (30d)
ActionQtyTypeStrikePremium
BuyCALL$95$9.14
SellCALL$100$6.44
BuyCALL$105$4.37
P/L at expiry vs today At expiry Today ±1σ
$82$100$118
Max Profit
$438
Max Loss
−$62
Net Debit (cost)
$62
Prob. of Profit
22%
Breakeven(s)
$95.62, $104.38
Implied Vol (ATM)
55%
Position Greeks
Δ
0.29
Γ
−0.249
Θ
1.03
ν
−1.13
Time decay (price held)

Simulation

Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.

Win rate
21%
Mean P/L
−$2
Median
−$62
Exp. move (1σ)
16%
5th pct
−$62
25th pct
−$62
75th pct
−$62
95th pct
$330
$-56$187$430
Analyze MRNA in the calculator → Share this pick ↗

Illustrative example at MRNA's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.

Implied volatility

MRNA typically trades with elevated implied volatility, so its options carry richer premiums. Implied volatility drives option prices, so it is worth checking the live chain before you trade.

Earnings & IV crush

MRNA's next earnings report is due around July 31, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.

Key figures

Market cap
$31.6B
Beta (vs market)
0.94
52-week range
$22.28–$81.40
Short interest
18.1% of float · 10.9 days to cover

With 18.1% of MRNA's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.

How to choose an options strategy for MRNA

Start with your outlook on MRNA, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:

Bullish

You expect MRNA to rise

Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.

Long Call → Bull Call Spread →

Bearish

You expect MRNA to fall

Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.

Long Put → Bear Put Spread →

Neutral

You expect MRNA to trade in a range

Sell an iron condor to collect premium while MRNA stays between two strikes, or write a covered call against shares you already own.

Iron Condor → Covered Call →

How we pick the best strategy

For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →

Open MRNA in the free calculator →

Frequently asked questions

What is the best options strategy for MRNA?

It depends on your outlook. Bullish traders often use a long call or bull call spread on MRNA; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.

Are MRNA options liquid enough to trade?

Moderna (MRNA) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.

How much money do I need to trade MRNA options?

Buying a single MRNA call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.

Is this financial advice?

No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade MRNA or any security. Do your own research.

What does Moderna do?

Moderna (MRNA) operates in the Biotechnology industry. The "About Moderna" section above gives a fuller picture of what the company does and how it earns money.

Does Moderna pay a dividend?

Moderna does not currently pay a dividend, so there is no ex-dividend assignment risk to plan around for options strategies.

When does Moderna next report earnings?

Moderna's next earnings are expected around July 31, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.

Price trend

Short term · 1M
▲ +74.8%
Mid term · 3M
▲ +59.4%
Long term · 1Y
▲ +161.6%

Tickers related to MRNA

Comparing MRNA with similar names can help you choose the best options strategy:

PFEPfizerJNJJohnson & JohnsonLLYEli Lilly

Company information

Headquarters
325 Binney Street, Cambridge, MA, 02142, United States
Industry
Biotechnology
Employees
4,700
CEO
Mr. Stéphane Bancel M.B.A.
Phone
617 714 6500
Website
www.modernatx.com

Best Options Strategy by Ticker →

Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.